Ocular Therapeutix (OCUL) Gross Margin (2016 - 2025)
Historic Gross Margin for Ocular Therapeutix (OCUL) over the last 12 years, with Q4 2025 value amounting to 2.21%.
- Ocular Therapeutix's Gross Margin fell 343300.0% to 2.21% in Q4 2025 from the same period last year, while for Dec 2025 it was 3.79%, marking a year-over-year decrease of 385300.0%. This contributed to the annual value of 3.79% for FY2025, which is 385300.0% down from last year.
- Ocular Therapeutix's Gross Margin amounted to 2.21% in Q4 2025, which was down 343300.0% from 10.01% recorded in Q3 2025.
- In the past 5 years, Ocular Therapeutix's Gross Margin ranged from a high of 39.21% in Q2 2024 and a low of 32.25% during Q1 2025
- In the last 5 years, Ocular Therapeutix's Gross Margin had a median value of 25.47% in 2021 and averaged 19.57%.
- Its Gross Margin has fluctuated over the past 5 years, first skyrocketed by 3205500bps in 2021, then plummeted by -633200bps in 2025.
- Ocular Therapeutix's Gross Margin (Quarter) stood at 25.77% in 2021, then fell by -2bps to 25.17% in 2022, then soared by 49bps to 37.54% in 2023, then dropped by -3bps to 36.54% in 2024, then crashed by -94bps to 2.21% in 2025.
- Its last three reported values are 2.21% in Q4 2025, 10.01% for Q3 2025, and 2.01% during Q2 2025.